abstract |
The invention relates to intravascular stents having in an inner surface an enzyme capable of catabolizing cholesterol and lipids, such as lipase, or cells that have been genetically modified to produce the enzyme, and to their use in the treatment or prevention of obstructive artheriosclerotic lesions in coronary and peripheral blood vessels, or prevention of restenosis in intra coronaric stents. |